Evidence map›Paper›PMID 40917905›Full record

ArticlePNAS nexus2025

Advancing synthesis-free and enzyme-free rewritable DNA memory through frameshift encoding and nanopore duplex interruption decoding.

Kai Tian, Sicheng Zhang, Sally Chen, Rugare G Chingarande, Chengrui Hou, Emily Ma, Jarett Ren, Shinghua Ding, Mia Stertzer, Binquan Luan and 3 more

Abstract read
In one paragraph

Article in PNAS nexus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Kai TianDepartment of Chemical and Biomedical Engineering, University of Missouri, Columbia, MO 65211, USA.
Sicheng ZhangDepartment of Physics, University of Missouri, Columbia, MO 65211, USA.
Sally ChenDepartment of Chemical and Biomedical Engineering, University of Missouri, Columbia, MO 65211, USA.
Rugare G ChingarandeDepartment of Chemical and Biomedical Engineering, University of Missouri, Columbia, MO 65211, USA.
Chengrui HouDepartment of Chemical and Biomedical Engineering, University of Missouri, Columbia, MO 65211, USA.
Emily MaDepartment of Chemical and Biomedical Engineering, University of Missouri, Columbia, MO 65211, USA.
Jarett RenDepartment of Chemical and Biomedical Engineering, University of Missouri, Columbia, MO 65211, USA.
Shinghua DingDepartment of Chemical and Biomedical Engineering, University of Missouri, Columbia, MO 65211, USA.
Mia StertzerDepartment of Chemical and Biomedical Engineering, University of Missouri, Columbia, MO 65211, USA.
Binquan LuanComputational Biology Center, IBM T. J. Watson Research, Yorktown Heights, NY 10598, USA.
Shi-Jie ChenDepartment of Physics, University of Missouri, Columbia, MO 65211, USA.ORCID https://orcid.org/0000-0002-8093-7244
Shi-You ChenDepartment of Surgery, University of Missouri, Columbia, MO 65211, USA.
Li-Qun GuDepartment of Chemical and Biomedical Engineering, University of Missouri, Columbia, MO 65211, USA.ORCID https://orcid.org/0000-0002-8710-6160

Funding

Fortilin, p53, and atherosclerosisR01HL117247 · NHLBI · UNIVERSITY OF WASHINGTON · PI CHEN, SHIYOU, FUJISE, KEN · 2013 to 2023
$4.7M
The Role of Gliotransmission in Cerebral IschemiaR01NS069726 · NINDS · UNIVERSITY OF MISSOURI-COLUMBIA · PI DING, SHINGHUA · 2010 to 2022
$3.3M
New methods for computational modeling of RNA structuresR35GM134919 · NIGMS · UNIVERSITY OF MISSOURI-COLUMBIA · PI SHI-JIE CHEN · 2020 to 2026
$3.3M
Novel Mechanisms underlying abdominal aortic aneurysm progressionR01HL173025 · NHLBI · UNIVERSITY OF MISSOURI-COLUMBIA · PI Shiyou Chen · 2024 to 2026
$1.9M
RECK as a Therapeutic Target for AtherosclerosisR01HL170056 · NHLBI · TULANE UNIVERSITY OF LOUISIANA · PI Chandrasekar Bysani, Shiyou Chen · 2025 to 2026
$1.3M
A novel therapeutic approach for Alzheimer Disease (AD)R21AG080715 · NIA · UNIVERSITY OF MISSOURI-COLUMBIA · PI DING, SHINGHUA · 2023 to 2023
$392k
NHLBI NIH HHS R01 HL117247NHLBI NIH HHS R01 HL170056NHLBI NIH HHS R01 HL173025NIA NIH HHS R21 AG080715NIGMS NIH HHS R35 GM134919NINDS NIH HHS R01 NS069726
6 · The paper itself

Abstract

DNA data storage is a promising alternative to conventional storage due to high density, low energy consumption, durability, and ease of replication. While information can be encoded into DNA via synthesis, high costs and the lack of rewriting capability limit its applications beyond archival storage. Emerging "hard drive" strategies seek to encode data onto universal DNA templates without de novo synthesis, using methods such as DNA nanostructures and base modifications. However, these approaches face challenges including complexity, low data density, enzymatic constraints, and reliance on costly instrumentation. Here, we introduce a DNA memory system based on frameshift encoding, inspired by viral ribosomal frameshifting, to enable rapid, cost-effective, and parallel data writing on a universal DNA template, without synthesis, enzymatic processing, or labeling. Information is encoded as checkpoint frameshifts by annealing microstaples of varying lengths at predefined sites along a long template strand. Data are decoded using MspA nanopore duplex interruption sequencing, which leverages a novel unzipping marker we discovered and frameshift-induced current signatures to resolve individual bits while sequentially unzipping tandem template-microstaple duplexes. Importantly, the duplex structure enables efficient, bit-specific rewriting through toehold-mediated strand displacement. This approach presents a scalable and versatile framework for DNA-based hard drives, with potential applications extending into in-memory computing, encryption, and dynamic biomolecular sensing.

Identifiers

PMID40917905
PMCPMC12412213

What Socratic holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.